ScreenerHero

0QKQ MindMaze Therapeutics Holding SA

LSE · GB · Healthcare · Biotechnology · mindmazetherapeutics.com
0.1350CHF-2.46%Mkt Cap: —P/E: —

MindMaze Therapeutics Holding SA operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally. The company offers MindPod syste…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap—
Enterprise Value20.14M USD
Revenue (TTM)1.36M USD
Gross Profit1.23M USD
Net Income (TTM)-11.50M USD
Revenue/Share0.01 CHF
Last Price0.1350 CHF
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees10
CountryGB
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-1.73
EV/Revenue14.76
P/S—
P/B0.64
EPS (TTM)-0.01
EPS (Forward)—
52W Range
0.13460% of range4.495
52W High4.495 CHF
52W Low0.1346 CHF
Profitability
Gross Margin90.39%
Oper. Margin-1144.71%
EBITDA Margin0.00%
Profit Margin0.00%
ROE—
ROA—
Growth
Revenue Growth1731.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-15.42M USD
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt-6.05M USD
Net Debt/EBITDA0.52
Balance Sheet
Debt/Equity0.07
Current Ratio1.40
Quick Ratio0.76
Book Value/Sh0.21 CHF
Cash/Share0.03 CHF
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 CHF
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split0.0025:1
Split DateMay 5, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.633.95M
Float51.25M
Insiders50.33%
Institutions18.56%
Technical
SMA 501.677 (-91.9%)
SMA 2002.579 (-94.8%)
Beta—
S&P 52W Chg15.78%
Avg Vol (30d)180.57K
Avg Vol (10d)77
Technical Indicators
RSI (14)16.5
MACD-0.2001
MACD Signal-0.2716
MACD Hist.+0.0715
BB Upper0.1744 CHF
BB Middle0.1512 CHF
BB Lower0.1280 CHF
BB Width30.64%
ATR (14)0.0339 CHF
Vol Ratio (20d)1.03x